EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AI reveals insights into link between CD33 and cognitive impairment in Alzheimer’s Disease

Tamara Raschka iD, Meemansa Sood iD, Bruce Schultz iD, Aybuge Altay iD, Christian Ebeling, Holger Fröhlich

PLOS Computational Biology · 2023

DOI: 10.1371/journal.pcbi.1009894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Computational Biology, 2023. Verfasst von Tamara Raschka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, Germany. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, Innovative Medicines Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Modeling biological mechanisms is a key for disease understanding and drug-target identification. However, formulating quantitative models in the field of Alzheimer’s Disease is challenged by a lack of detailed knowledge of relevant biochemical processes. Additionally, fitting differential equation systems usually requires time resolved data and the possibility to perform intervention experiments, which is difficult in neurological disorders. This work addresses these challenges by employing the recently published Variational Autoencoder Modular Bayesian Networks (VAMBN) method, which we here trained on combined clinical and patient level gene expression data while incorporating a disease focused knowledge graph. Our approach, called iVAMBN, resulted in a quantitative model that allowed us to simulate a down-expression of the putative drug target CD33, including potential impact on cognitive impairment and brain pathophysiology. Experimental validation demonstrated a high overlap of molecular mechanism predicted to be altered by CD33 perturbation with cell line data. Altogether, our modeling approach may help to select promising drug targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionHumansBayes TheoremArtificial IntelligenceSialic Acid Binding Ig-like Lectin 3

Substanzen

CD33 protein, humanSialic Acid Binding Ig-like Lectin 3

Autor:innen und Institutionen

  • Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, Germany.
  • Bonn-Aachen International Center for Information Technology (B-IT), University of Bonn, Bonn, Germany.
  • Fraunhofer Center for Machine Learning, Sankt Augustin, Germany.

ORCID-Profile: Tamara Raschka, Meemansa Sood, Bruce Schultz, Aybuge Altay

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • Innovative Medicines Initiative
  • Fraunhofer Center for Machine Learning

Zitieren

APA

Raschka, T., Sood, M., Schultz, B., Altay, A., Ebeling, C., & Fröhlich, H. (2023). AI reveals insights into link between CD33 and cognitive impairment in Alzheimer’s Disease. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1009894

Vancouver

Raschka T, Sood M, Schultz B, Altay A, Ebeling C, Fröhlich H. AI reveals insights into link between CD33 and cognitive impairment in Alzheimer’s Disease. PLOS Computational Biology. 2023. doi:10.1371/journal.pcbi.1009894

BibTeX
@article{Raschka2023,
  author = {Raschka, Tamara and Sood, Meemansa and Schultz, Bruce and Altay, Aybuge and Ebeling, Christian and Fröhlich, Holger},
  title = {AI reveals insights into link between CD33 and cognitive impairment in Alzheimer’s Disease},
  journal = {PLOS Computational Biology},
  year = {2023},
  doi = {10.1371/journal.pcbi.1009894}
}
Kostenlos starten →